In our study using June 2024 data on fee-for-service Medicaid in 50 states and Washington, D.C., only 13 covered GLP-1s for weight loss in adults
Physical Activity: Regular exercise complements the appetite-suppressing effects of GLP-1 agonists
& Clemmensen, C
Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders
Healthcare professionals and patients should be aware that individual responses may differ significantly from trial averages, and that fatigue persisting beyond a few weeks or worsening at any stage warrants clinical review
The most common side effects reported in retatrutide results from Phase 2 trials were gastrointestinal in nature, including nausea (affecting up to 45% of participants at higher doses), diarrhea, vomiting, and constipation